What do systematic reviews say?

Omega‐3 (with risperidone and previous ASM) vs risperidone and previous ASM only

Omega‐3 (with risperidone and previous ASM) showed no clear difference in proportion of individuals withdrawing from treatment compared with risperidone and previous ASM only (low certainty).

• Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy 2022 · Cochrane Headline outcomes only
  RR 0.65 [0.12, 3.59]
  1 study · 61 participants
  Low

Omega‐3 (with risperidone and previous ASM) vs risperidone and previous ASM only

The review found no eligible studies for this question.

• Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ More compressed schedules vs less compressed schedules

• Adapting shift work schedules for sleep quality, sleep duration, and sleepiness in shift workers 2023 · Cochrane Headline outcomes only
  no estimate extracted
  25 participants
  Very low

Summary of findings table ‐ More compressed schedules vs less compressed schedules

• Adapting shift work schedules for sleep quality, sleep duration, and sleepiness in shift workers 2023 · Cochrane Headline outcomes only
  no estimate extracted
  30 participants
  Very low

Summary of findings table ‐ More compressed schedules vs less compressed schedules

The review found no eligible studies for this question.

• Adapting shift work schedules for sleep quality, sleep duration, and sleepiness in shift workers 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ More compressed schedules vs less compressed schedules

The review found no eligible studies for this question.

• Adapting shift work schedules for sleep quality, sleep duration, and sleepiness in shift workers 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: endovenous ablation and compression vs compression alone

Summary of findings: endovenous ablation and compression leads to higher ulcer healing time (measured as days from randomisation and… compared with compression alone (high certainty).

• Endovenous ablation for venous leg ulcers 2023 · Cochrane Headline outcomes only
  HR 1.41 [1.36, 1.47]
  2 studies · 466 participants
  High

Summary of findings: endovenous ablation and compression vs compression alone

Summary of findings: endovenous ablation and compression showed no clear difference in proportion of ulcers healed at 90 days (90 days compared with compression alone (moderate certainty).

• Endovenous ablation for venous leg ulcers 2023 · Cochrane Headline outcomes only
  RR 1.14 [1, 1.3]
  2 studies · 466 participants
  Moderate
• Endovenous ablation for venous leg ulcers 2023 · Cochrane Headline outcomes only
  RR 1.08 [1.02, 1.14]
  2 studies · 505 participants
  Moderate

Summary of findings: endovenous ablation and compression vs compression alone

Summary of findings: endovenous ablation and compression showed no clear difference in ulcer recurrence (1 year compared with compression alone (low certainty).

• Endovenous ablation for venous leg ulcers 2023 · Cochrane Headline outcomes only
  RR 0.29 [0.03, 2.48]
  2 studies · 460 participants
  Low

Summary of findings: endovenous ablation and compression vs compression alone

• Endovenous ablation for venous leg ulcers 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 450 participants
  Low

Chlorhexidine rinse (0.12% and 0.2%, pre- and post-extraction) vs placebo or no treatment

• Local interventions for the management of alveolar osteitis (dry socket) 2022 · Cochrane All outcomes

  Follow-up: median 7 days
  3 trials reported no adverse events. 1 study reported adverse events (alterations in taste, bad taste, staining) in 24/62 in chlorhexidine group versus 0/40 in placebo group, Peto OR = 8.42 (95% CI 3.31 to 21.39). A…
  6 studies
  GRADE not reported

Exercise prescription plus the use of a wearable fitness tracker vs exercise

The review found no eligible studies for this question.

• Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise prescription plus the use of a wearable fitness tracker vs exercise

The review found no eligible studies for this question.

• Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise prescription plus the use of a wearable fitness tracker vs exercise

The review found no eligible studies for this question.

• Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise prescription plus the use of a wearable fitness tracker vs exercise

The review found no eligible studies for this question.

• Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise prescription plus the use of a wearable fitness tracker vs exercise

The review found no eligible studies for this question.

• Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise prescription plus the use of a wearable fitness tracker vs exercise

The review found no eligible studies for this question.

• Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Subperiosteal prepared (SPP) wound closure after tooth extraction vs Epiperiosteal prepared (EPP) wound closure after tooth extraction

Subperiosteal prepared (SPP) wound closure after tooth extraction showed no clear difference in MRONJ after tooth extraction (incidence proportion) compared with epiperiosteal prepared (EPP) wound closure after tooth extraction (low certainty).

• Interventions for managing medication‐related osteonecrosis of the jaw 2022 · Cochrane All outcomes

  6 months
  RR 0.09 [0.00, 1.56]
  1 study · 132 participants
  Low

Summary of findings table ‐ Oral classical immunosuppressants (betamethasone) vs oral classical immunosuppressants (azathioprine, methotrexate, prednisolone)

Summary of findings table ‐ Oral classical immunosuppressants… showed no clear difference in short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with oral classical immunosuppressants (azathioprine, methotrexate,… (low certainty).

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  RR 1.67 [0.96, 2.88]
  2 studies · 80 participants
  Low

Summary of findings table ‐ Oral classical immunosuppressants (betamethasone) vs oral classical immunosuppressants (azathioprine, methotrexate, prednisolone)

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 154 participants
  Very low